Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2003
08/14/2003CA2475112A1 Anti-infarction molecules
08/14/2003CA2475093A1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
08/14/2003CA2474974A1 Cytoprotective benzofuran derivatives
08/14/2003CA2474917A1 Granzyme b inhibitors
08/14/2003CA2474888A1 Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ace inhibitors for preventing heart failure and other age-related dysfunctions of organs, age-related diseases and for prolonging lifespan
08/14/2003CA2474783A1 Pluripotent embryonic-like stem cells derived from teeth and uses thereof
08/14/2003CA2474748A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003CA2474687A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of thereof as medicaments
08/14/2003CA2474508A1 Ansamycins having improved pharmacological and biological properties
08/14/2003CA2474424A1 Salts of valsartan
08/14/2003CA2474283A1 Amino acid sequences capable of facilitating penetration across a biological barrier
08/14/2003CA2474168A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003CA2474027A1 Water soluble phenylglycine derivatives
08/14/2003CA2474016A1 A combination for treating cold and cough
08/14/2003CA2473499A1 Minrs as modifiers of insulin receptor signaling and methods of use
08/14/2003CA2473181A1 Quinoline derivatives as npy antagonists
08/14/2003CA2466294A1 Hexa-, hepta-, and octapeptides having antiangiogenic activity
08/14/2003CA2455881A1 A stable pharmaceutical formulation comprising torsemide modification ii
08/13/2003EP1335202A1 Method for screening compounds being modulators of neuromediators
08/13/2003EP1335024A1 Antibody inhibiting vplf activity
08/13/2003EP1334973A1 Preventive or therapeutic medicines for diabetes containing fused-heterocycle compounds or their salts
08/13/2003EP1334730A2 Platelet-specific chimeric immunoglobulin and methods of use therefor
08/13/2003EP1334719A2 Pentafluorobenzenesulfonamides and analogs
08/13/2003EP1334718A1 Drug composition comprising dipeptydyl aldehyde derivative
08/13/2003EP1334358A1 Targeting cells having mad2 mutation for treatment and/or prevention of disease
08/13/2003EP1334201A2 Dna expression vectors
08/13/2003EP1334194A2 Imaging, diagnosis and treatment of disease
08/13/2003EP1334179A2 A human serpin secreted from lymphoid cells lsi-01
08/13/2003EP1334174A2 Paramyxovirus vector for gene transfer to the cardiovascular system
08/13/2003EP1334102A1 Bombesin receptor antagonists
08/13/2003EP1334100A1 Bombesin receptor antagonists
08/13/2003EP1334094A1 Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles
08/13/2003EP1334089A1 Quinoline derivatives as nk-3 and nk-2 antagonists
08/13/2003EP1334088A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
08/13/2003EP1334087A1 Cycloalkylfluorosulfonamide derivatives
08/13/2003EP1334086A1 Phenoxyphenyl alkane sulfonates
08/13/2003EP1333887A2 Combination therapy comprising anti-diabetic and anticonvulsant agents
08/13/2003EP1333855A1 Use of melagatran for manufacture of a medicament for the treatment of ischemic disorders
08/13/2003EP1333853A1 Growth factor complex
08/13/2003EP1333841A2 M. tuberculosis chaperonin 10 and uses thereof
08/13/2003EP1333840A2 M. tuberculosis chaperonin 60.1 and uses thereof
08/13/2003EP1333837A1 Improved treatment
08/13/2003EP1333833A2 Novel compounds
08/13/2003EP1333827A2 Estrogen receptor modulators
08/13/2003EP1333821A2 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
08/13/2003EP1333816A2 Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same
08/13/2003EP1333809A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
08/13/2003EP1333719A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
08/13/2003EP1222193B1 Imidazole derivatives as phosphodiesterase vii inhibitors
08/13/2003EP1220845B1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors
08/13/2003EP1143942B1 Use of gaba-b receptor ligands for the manufacture of medicaments for the treatment of neurodegenerative diseases
08/13/2003EP1073658B1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
08/13/2003EP0971948B1 Inhibitors for urokinase receptor
08/13/2003EP0891328B1 Peptidyl compounds having mmp and tnf inhibitory activity
08/13/2003EP0879233B1 Chinoline and benzimidazole derivatives as bradykinin agonists
08/13/2003EP0751774B1 Hypocholesterolemic mercaptoacetylamide disulfide derivatives
08/13/2003EP0572553B1 Recombinant thrombin receptor and related pharmaceuticals
08/13/2003CN1436305A Hypotensors
08/13/2003CN1436235A Anti-angiogenic polypeptides
08/13/2003CN1436196A Pyridine-2-yl-aminoalkyl carbonyl glycyl-beta-alanine and derivs. thereof
08/13/2003CN1436195A Integrin binding peptide derivatives
08/13/2003CN1436192A HMG-CoA reductase inhibitors and method
08/13/2003CN1436188A 1,3,8-triaza-spiroÒÇö4,5ÒÇòdecan-4-one derivs. as neurokinin receptor antagonists
08/13/2003CN1436185A Thrombin receptor antagonists
08/13/2003CN1436174A HMG-CoA reductase inhibitors and their use as medicaments for treatment of cholesterol related diseases
08/13/2003CN1436173A Hydroxy formamidine derivs. and medicines contg. same
08/13/2003CN1436172A 1,2-dihydropyridine compounds, process for preparation of same and use thereof
08/13/2003CN1436168A Beta-amino acid nitrile derivs.
08/13/2003CN1436077A Stabilized pharmaceutical compositions contg. calcium channel blockers
08/13/2003CN1436076A Method of treating cardiovascular disease
08/13/2003CN1436072A Composition, kits, and methods for promoting defined health benefits
08/13/2003CN1436047A Compositions and methods for improving vascular health
08/13/2003CN1435429A Buxanines compounds with cardiovascular activity and cardiovascular and cerebrovascular medicine using them as active component
08/13/2003CN1435428A Cyclovirobuxine D salt and its preparation and use, and process for preparing said preparation
08/13/2003CN1435424A High content ginkgo extract and process for producing same
08/13/2003CN1435250A Method for preparing oralÔÇ£mailuolingÔÇØ solid preparation for injection
08/13/2003CN1435242A Chinese medicine preparation for antihypertension and invigorating pulse
08/13/2003CN1435237A Chinese medicine powder for treating cerebrovascular diseases
08/13/2003CN1435230A ÔÇ£ChuanshenÔÇØ capsule and preparing process thereof
08/13/2003CN1435212A Medicine for treating hypertension and method for preparing medicinal tea thereof
08/13/2003CN1435178A Osmosis pump controlled release preparation contg. Chinese medicine of cyclovirobuxine D, and preparing method thereof
08/13/2003CN1117746C Method for preparing substd. pyridines and pyridines obtained thereby
08/13/2003CN1117738C Endothelin antagonists
08/13/2003CN1117584C Preparation for external use for treating hypertension and hyperlipemia and its preparing method
08/13/2003CN1117581C Chinese medicine for treating angina pectonis
08/13/2003CN1117569C Bicyclic fibrinogen antagonists
08/13/2003CN1117566C Combination therapy comprising amlodipine and statin compound
08/12/2003US6605742 Rheumatic diseases; antiarthritic agents; antitumor agents
08/12/2003US6605722 Tyrosine derivatives with anti-leukotrienen activity
08/12/2003US6605713 Contacting D-nucleic acids with a racemic mixture of the target molecule and allow for binding; producing L-nucleic acids; in vitro selection of DNA/RNA with high binding affinity and stability
08/12/2003US6605712 Isolated DNA comprising a radiation inducible promoter linked to a region encoding a polypeptide; use for regulating polypeptide expression and inhibiting tumor growth; anticarcinogenic agent
08/12/2003US6605642 Inhibitors of formation of advanced glycation endproducts (AGES)
08/12/2003US6605641 20-HETE antagonists and agonists
08/12/2003US6605640 Treating a retinal or choroidal vascular or hereditary disease by topically administering an acetylcholine esterase inhibitor, e.g., Phospholine Iodide; age related macular degeneration disease; diabetic retinopathy
08/12/2003US6605639 Treating and/or preventing diseases alleviated by retinoid X receptor ligand dependent transcriptional regulation using ascochlorin or derivatives
08/12/2003US6605637 Lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
08/12/2003US6605636 Atorvastatin hemi-calcium form VII
08/12/2003US6605635 N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof
08/12/2003US6605634 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
08/12/2003US6605633 Such as 5-Bromo-2-phenyl-1H-indole-3-butanoic acid
1 ... 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 ... 1595